PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease
The strategic collaboration aims to accelerate drug discovery in neurodegenerative disease Joint research programmes against multiple undisclosed targets to be initiated over the next two years PharmEnable to receive an upfront cash payment and potential milestone...
PharmEnable awarded PLG Collaboration Deal of the Year Award
We are delighted that our business development team has been recognised with the prestigious Collaboration Deal of the Year Award by the Pharmaceutical Licensing Group for our shared-risk collaboration with Sosei Heptares, an international biopharmaceutical group. The...
How an AI drug discovery collaboration between Sosei Heptares and PharmEnable is accelerating complex science: generating new hit molecules against a difficult GPCR target
Artificial Intelligence (AI) is becoming an increasingly important part of drug discovery – as demonstrated by the significant progress in the ongoing collaboration between Sosei Heptares and PharmEnable focused on a challenging peptidergic G protein-coupled receptor...
PharmEnable selected for Tech Nation’s programme Applied AI 3.0
PharmEnable has been selected to join Applied AI 3.0, an established 5-month programme aimed at accelerating the growth of successful startups in AI. Delivered by the team at Tech Nation, the cohort is comprised of early-stage UK tech companies applying AI in...
PharmEnable and LifeArc partner to discover novel oral antiviral drugs to treat coronaviruses
PharmEnable is delighted to announce that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against...
PharmEnable wins Rising Star at UKBAA Angel Investment Award
We are delighted to announce that PharmEnable has been awarded Rising Star in the DeepTech Investment of the Year category at the UKBAA Angel Investment Awards 2021. The annual UKBAA Angel Investment awards, sponsored by Playfair Capital, recognise acknowledge the...
PharmEnable welcome new Director of Drug Discovery
PharmEnable are delighted to welcome Dr James Dale as Director of Drug Discovery. Dr Dale has over 18 years of experience in research and drug discovery, focusing on identifying and delivering novel therapeutics. He earned a PhD in synthetic organic chemistry and has...
PharmEnable and Sosei Heptares enter technology collaboration for AI-driven drug discovery against challenging GPCR target
PharmEnable is delighted to announce that we have entered a new partnership with Sosei Heptares. This collaboration will drive a novel drug discovery programme against a challenging G protein-coupled receptor (GPCR) target, which is associated with neurological...
PharmEnable’s CEO named as one of BioBeat’s 30 Movers and Shakers 2020
We are delighted to announce that PharmEnable’s CEO, Dr Hannah Sore, has been named as one of the top 30 women leaders and innovators in the BioBeat’20 report. The Movers and Shakers in BioBusiness 2020 list showcases outstanding innovators in the UK bioscience scene...
Our CEO joins live debate panel this week
Our CEO, Dr Hannah Sore, will be speaking at this week’s #coffeebuddies debate series, in association with One Nucleus. The virtual #coffeebuddies debates are a fringe event to ON Helix and keep the life sciences community connected, engaged, informed and entertained....
Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion
£1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment fundsUsing advanced medicinal chemistry and AI approaches to develop highly complex and specific drug candidate moleculesWill enable in-house drug discovery across a...
PharmEnable appoints new Board Chair
PharmEnable are delighted to announce the appointment of Dr Jane Dancer as Chair of our Board of Directors. She brings with her a wealth of experience in business development and driving company growth. Her previous roles include Chief Business Officer at F-star...
